Statement Of Cash Flows [Abstract]

Xspray Pharma - Filing #690674

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
106 604 SEK
55 983 SEK
Adjustments for decrease (increase) in trade and other receivables
2 942 SEK
5 712 SEK
Adjustments for increase (decrease) in trade and other payables
633,000 SEK
10 087 SEK
Cash flows from (used in) investing activities [abstract]
Payments for development project expenditure
103 820 SEK
94 651 SEK
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of warrants
SEK
4 375 SEK
Payments for share issue costs
4 876 SEK
29,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.